Literature DB >> 15175011

Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain.

Hidefumi Oshita1, John D Sandy, Kiichi Suzuki, Atsushi Akaike, Yun Bai, Tomohiro Sasaki, Katsuji Shimizu.   

Abstract

Extracts of normal mature articular cartilage contain aggrecan molecules which bear the G1 domain (the N-terminal globular domain of aggrecan) and are C-terminally truncated by proteolysis at a number of sites. A proportion of these molecules are generated by an aggrecanase and/or matrix-metalloproteinase-mediated cleavage in the IGD (interglobular domain between the G1 and G2 domains of aggrecan). However, the proteinase(s) responsible for formation of the majority of the larger G1-G2 and glycosaminoglycan-bearing truncated species is (are) unknown. N-terminal sequencing of aggrecan core fragments generated by m-calpain digestion of bovine aggrecan has identified four novel cleavage sites: one within the CS (chondroitin sulphate)-1 domain (at one or more of the bonds Ser1229-Val1230, Ser1249-Val1250, Ser1287-Val1288, Gly1307-Val1308 and Ser1346-Val1347), two within the IGD (at bonds Ala474-Ala475 and Gly365-Gly366) and one within the KS (keratan sulphate) domain (at Ala719-Ala720). A new monoclonal antibody (SK-28) to the C-terminal neoepitope at M710VTQVGPGVA719 showed that aggrecan products generated by this cleavage are present in high abundance in mature bovine articular cartilage extracts. We conclude that m-calpain, or an unidentified proteinase with the capacity to cleave at the same site, is active during aggrecan biosynthesis/secretion by mature chondrocytes or in the matrix of mature bovine articular cartilage in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175011      PMCID: PMC1133938          DOI: 10.1042/BJ20040113

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  Association of the calpain/calpastatin network with subcellular organelles.

Authors:  Joshua L Hood; Barbara B Logan; Anthony P Sinai; William H Brooks; Thomas L Roszman
Journal:  Biochem Biophys Res Commun       Date:  2003-10-31       Impact factor: 3.575

2.  Activation of neutrophil calpain following its translocation to the plasma membrane induced by phorbol ester or fMet-Leu-Phe.

Authors:  S Pontremoli; E Melloni; F Salamino; M Patrone; M Michetti; B L Horecker
Journal:  Biochem Biophys Res Commun       Date:  1989-04-28       Impact factor: 3.575

Review 3.  Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans.

Authors:  B Caterson; J E Christner; J R Baker; J R Couchman
Journal:  Fed Proc       Date:  1985-02

4.  Electrophoresis of 35S-labeled proteoglycans on polyacrylamide-agarose composite gels and their visualization by fluorography.

Authors:  S L Carney; M T Bayliss; J M Collier; H Muir
Journal:  Anal Biochem       Date:  1986-07       Impact factor: 3.365

5.  Separation and characterization of two populations of aggregating proteoglycans from cartilage.

Authors:  D Heinegård; J Wieslander; J Sheehan; M Paulsson; Y Sommarin
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

6.  Aggrecan protects cartilage collagen from proteolytic cleavage.

Authors:  Michael A Pratta; Wenqing Yao; Carl Decicco; Micky D Tortorella; Riu-Qin Liu; Robert A Copeland; Ronald Magolda; Robert C Newton; James M Trzaskos; Elizabeth C Arner
Journal:  J Biol Chem       Date:  2003-07-30       Impact factor: 5.157

7.  Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate. Monoclonal antibodies to cartilage proteoglycan.

Authors:  B Caterson; J E Christner; J R Baker
Journal:  J Biol Chem       Date:  1983-07-25       Impact factor: 5.157

8.  Studies on the hyaluronate binding properties of newly synthesized proteoglycans purified from articular chondrocyte cultures.

Authors:  J D Sandy; A H Plaas
Journal:  Arch Biochem Biophys       Date:  1989-06       Impact factor: 4.013

9.  Cartilage proteoglycans. Structure and heterogeneity of the protein core and the effects of specific protein modifications on the binding to hyaluronate.

Authors:  T E Hardingham; R J Ewins; H Muir
Journal:  Biochem J       Date:  1976-07-01       Impact factor: 3.857

10.  Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus.

Authors:  Juliette Gafni; Evan Hermel; Jessica E Young; Cheryl L Wellington; Michael R Hayden; Lisa M Ellerby
Journal:  J Biol Chem       Date:  2004-02-23       Impact factor: 5.157

View more
  12 in total

1.  Selective and non-selective metalloproteinase inhibitors reduce IL-1-induced cartilage degradation and loss of mechanical properties.

Authors:  Christopher G Wilson; Ashley W Palmer; Fengrong Zuo; Elsie Eugui; Stacy Wilson; Rebecca Mackenzie; John D Sandy; Marc E Levenston
Journal:  Matrix Biol       Date:  2006-11-11       Impact factor: 11.583

2.  Matrix metalloproteinases are not essential for aggrecan turnover during normal skeletal growth and development.

Authors:  Christopher B Little; Clare T Meeker; Rosalind M Hembry; Natalie A Sims; Kate E Lawlor; Sue B Golub; Karena Last; Amanda J Fosang
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  Investigating ADAMTS-mediated aggrecanolysis in mouse cartilage.

Authors:  Heather Stanton; Suzanne B Golub; Fraser M Rogerson; Karena Last; Christopher B Little; Amanda J Fosang
Journal:  Nat Protoc       Date:  2011-03-03       Impact factor: 13.491

4.  Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.

Authors:  P Patwari; G Gao; J H Lee; A J Grodzinsky; J D Sandy
Journal:  Osteoarthritis Cartilage       Date:  2005-04       Impact factor: 6.576

5.  Chondroitin sulfate N-acetylgalactosaminyltransferase 1 is necessary for normal endochondral ossification and aggrecan metabolism.

Authors:  Takashi Sato; Takashi Kudo; Yuzuru Ikehara; Hiroyasu Ogawa; Tomoko Hirano; Katsue Kiyohara; Kozue Hagiwara; Akira Togayachi; Masatsugu Ema; Satoru Takahashi; Koji Kimata; Hideto Watanabe; Hisashi Narimatsu
Journal:  J Biol Chem       Date:  2010-12-10       Impact factor: 5.157

6.  Adult bone marrow stromal cell-based tissue-engineered aggrecan exhibits ultrastructure and nanomechanical properties superior to native cartilage.

Authors:  H-Y Lee; P W Kopesky; A Plaas; J Sandy; J Kisiday; D Frisbie; A J Grodzinsky; C Ortiz
Journal:  Osteoarthritis Cartilage       Date:  2010-08-06       Impact factor: 6.576

7.  Suppression of MMP activity in bovine cartilage explants cultures has little if any effect on the release of aggrecanase-derived aggrecan fragments.

Authors:  Bijue Wang; Pingping Chen; Anne-Christine Bay Jensen; Morten A Karsdal; Suzi H Madsen; Bodil-Cecilie Sondergaard; Qinlong Zheng; Per Qvist
Journal:  BMC Res Notes       Date:  2009-12-18

8.  Characterization of proteoglycan production and processing by chondrocytes and BMSCs in tissue engineered constructs.

Authors:  J T Connelly; C G Wilson; M E Levenston
Journal:  Osteoarthritis Cartilage       Date:  2008-02-21       Impact factor: 6.576

9.  Chondrocytes and meniscal fibrochondrocytes differentially process aggrecan during de novo extracellular matrix assembly.

Authors:  Christopher G Wilson; James F Nishimuta; Marc E Levenston
Journal:  Tissue Eng Part A       Date:  2009-07       Impact factor: 3.845

10.  Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair.

Authors:  Christopher B Little; Clare T Meeker; Suzanne B Golub; Kate E Lawlor; Pamela J Farmer; Susan M Smith; Amanda J Fosang
Journal:  J Clin Invest       Date:  2007-05-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.